Related Experiment Videos
Constipation in childhood: a controlled comparison between lactulose and standardized senna
Current Medical Research and Opinion
|January 1, 1977
Summary
Lactulose is a highly effective and well-tolerated treatment for chronic constipation in children, significantly improving stool consistency compared to senna. Senna treatment resulted in substantially more frequent side effects in pediatric patients.
Area of Science:
- Pediatrics
- Gastroenterology
- Pharmacology
Background:
- Chronic constipation is a common pediatric condition requiring effective treatment.
- Laxatives such as lactulose and senna are frequently used for pediatric constipation.
- Understanding the comparative efficacy and tolerability of these treatments is crucial.
Purpose of the Study:
- To compare the efficacy and tolerability of lactulose versus senna in treating chronic constipation in children.
- To evaluate the impact of these treatments on stool consistency and patient-reported side effects.
Main Methods:
- A 3-week crossover trial involving 21 children under 15 with chronic constipation.
- Participants received either lactulose or senna for one week, followed by a week of no treatment, and then the alternative treatment.
- Parental diaries recorded stool characteristics and side effects.
Main Results:
- A significantly greater number of days with normal stools were observed during lactulose treatment compared to senna.
- The frequency and number of reported side effects were significantly higher with senna than with lactulose (p < 0.001).
Conclusions:
- Lactulose is recommended as an effective and well-tolerated treatment for pediatric chronic constipation.
- Lactulose demonstrates superior efficacy and tolerability over senna in this pediatric population.